Skip to main content
Premium Trial:

Request an Annual Quote

Diaxonhit, One Lambda Renew Distribution Partnership for Transplant Dx

NEW YORK (GenomeWeb) – Diaxonhit today announced that its affiliate InGen has renewed an exclusive deal to distribute One Lambda's transplantation diagnostic tests in France.

Financial and other details of the partnership were not disclosed.

Thermo Fisher Scientific's One Lambda develops and distributes several lines of HLA typing and antibody detection assays that use serological, molecular, ELISA, flow cytometry, and Luminex's xMap technologies. The tests are used to assess the compatibility between donor and recipient before transplantation, and to follow-up on transplanted patients by monitoring potential organ rejection.

Diaxonhit is an integrated in vitro diagnostics firm that distributes IVD products for transplantation, infectious diseases, and cancer to the French market.

Paris, France-based Diaxonhit was formed in 2012 when Exonhit acquired InGen Biosciences. Thermo Fisher acquired One Lambda, also in 2012.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.